Drugs / Lidocaine injection
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06799494 Background | Aug 2025 → Sep 2028 expected | human papilloma virus infection | Emory University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lidocaine injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06799494 ↗ |
| Route | Subcutaneous | “Lidocaine 1% will be injected intradermally and subcutaneously into the margin of the lymph node to be sampled to numb the area.” NCT06799494 ↗ |